Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia - Takeaways - MDSpire

Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia

  • By

  • Emily C Tucker

  • Bianca Angelica

  • Ryan M Mathias

  • Louisa Edwards

  • Robert V Bryant

  • Samuel P Costello

  • March 13, 2025

  • 0 min

Share

  • 1

    Fecal microbiota transplantation (FMT) has been available in South Australia since 2013 for treating Clostridioides difficile infection (CDI).

  • 2

    Out of 98 potential donors, 61 passed screening, with 14% ineligibility due to extended-spectrum β-lactamase-producing organisms.

  • 3

    FMT showed an overall primary cure rate of 84%, with varying success rates for recurrent, refractory, severe, and fulminant CDI.

  • 4

    Serious adverse events occurred in 3% of patients, with no deaths directly linked to FMT during the study period.

  • 5

    The study highlights the efficacy and safety of FMT for CDI, suggesting further research is needed for severe and fulminant cases.

Original Source(s)

Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia

  • by Emily C Tucker, Bianca Angelica, Ryan M Mathias, Louisa Edwards, Robert V Bryant, Samuel P Costello

  • March 13, 2025

Related Content

Defining Fulminant Clostridioides difficile Infections: Assessing the Utility of Hypotension as a Diagnostic Criterion

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.

Framework Targets Hospital-Onset UTIs

The expert panel outlines surveillance, device management, and diagnostic stewardship strategies to address both catheter-associated and non–catheter-associated infections.